1. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
2. |
Antihypertensive therapy in stroke: how low should you go? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 3-4
Charles Bankhead,
Preview
|
|
摘要:
Antihypertensive therapy is commonly employed in the management of patients with acute stroke, both ischaemic and haemorrhagic. However, some evidence has suggested that overly aggressive lowering of BP might cause more harm than good in some patients with stroke. Additionally, a US study evaluating clinical management standards has found that many patients with stroke receive unnecessary antihypertensive therapy. Two new studies have provided evidence to suggest that aggressive BP management is a feasible and useful clinical goal in acute stroke. One of these studies showed a lower rate of stroke recurrence in association with lower diastolic BP, and the other demonstrated improved cerebral blood flow with aggressive BP management in acute haemorrhagic stroke, though not in all patients. The findings were reported at the American Stroke Association 25th International Stroke Conference [New Orleans, US; February 2000].
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
3. |
Sildenafil sales over the Internet: rise in issues |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
4. |
Optimising sedation in the ICU |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
5. |
Follitropin beta cost effective in IVF |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
6. |
Zanamivir: GW licks its wounds after NICE bites |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 7-8
Mark Greener,
Preview
|
|
摘要:
Glaxo Wellcome's zanamivir ['Relenza'] recently proved that the UK's new National Institute for Clinical Excellence (NICE) bites. With many other countries considering introducing similar health technology assessment systems, the time seems right to examine some lessons the pharmaceutical industry can learn as Glaxo Wellcome (GW) licks its wounds.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
7. |
Lenograstim improves survival without compromising QOL in SCLC |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
8. |
'Implanon' leads the way |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
9. |
Telomerase gene therapy for cirrhosis? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
10. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1230,
2000,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|